Barlow Carrolee bought SUPN
February 18, 2026 · Form 4 insider transaction
Barlow Carrolee bought 2,989 shares of Supernus Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,989
Price
$0.00
Total value
N/A
InsiderBarlow Carrolee
Role—
SecurityRestricted Stock Unit
Transaction codeA: Grant or award
Transaction dateFebruary 18, 2026
Filing dateFebruary 20, 2026
Shares owned after2,989
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.; These restricted stock units will be settled in common stock upon vesting, which will occur on February 18, 2027.